7-Bromo-1-heptene
7-Bromo-1-heptene structure
|
Common Name | 7-Bromo-1-heptene | ||
|---|---|---|---|---|
| CAS Number | 4117-09-3 | Molecular Weight | 177.08200 | |
| Density | 1.162 g/mL at 25 °C(lit.) | Boiling Point | 27 °C1 mm Hg(lit.) | |
| Molecular Formula | C7H13Br | Melting Point | 0°C | |
| MSDS | Chinese USA | Flash Point | 137 °F | |
| Symbol |
GHS02, GHS07 |
Signal Word | Warning | |
|
Synthesis of a metabolically stable modified long-chain fatty acid salt and its photolabile derivative.
J. Lipid Res. 32(5) , 843-57, (1991) An analogue of the long-chain fatty acid salt, sodium stearate, was synthesized in which the hydrogen atoms at carbons 2, 3, and 18 were replaced by fluorine. The key step in the synthesis was the addition of 3-iodo-2,2,3,3-tetrafluoropropanoic acid amide to ... |
|
|
Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress.
ChemMedChem 4(7) , 1095-105, (2009) A series of benzolactam compounds were synthesized, some of which caused a concentration-dependent increase in sAPPalpha and decrease in Abeta production in the concentration range of 0.1-10 microM. Moreover, some compounds showed neuroprotective effects in t... |
|
|
Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides.
Bioorg. Med. Chem. 16(1) , 437-45, (2008) Inhibitors of histone deacetylases (HDACs) are a promising class of anticancer agents that effect gene regulation. To know the interaction of aliphatic cap groups with HDACs, cyclic tetrapeptide and bicyclic peptide disulfide hybrids were synthesized without ... |